Piper Sandler Has Lowered Expectations for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price
Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) had its price objective lowered by analysts at Piper Sandler from $140.00 to $115.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the biopharmaceutical company’s stock. Piper Sandler’s target price would indicate a potential upside of 195.93% from the stock’s previous […]
Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) had its price objective lowered by analysts at Piper Sandler from $140.00 to $115.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the biopharmaceutical company’s stock. Piper Sandler’s target price would indicate a potential upside of 195.93% from the stock’s previous […]
